Low-dose aspirin can downregulate progesterone resistance and increase the expression of LIF in endometriosis during the implantation window
Low-dose aspirin treatment in endometriosis rats downregulated progesterone resistance and increased leukemia inhibitory factor (LIF) in the endometrium and serum, potentially improving endometrial receptivity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure via openalex
- Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex
- Eutopic Endometrium in Women with Endometriosis: Ground Zero for the Study of Implantation Defects via openalex
- Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol via openalex
- H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis via openalex
- Implantation Defects in Infertile Women with Endometriosis via openalex
- Implications of immune dysfunction on endometriosis associated infertility via openalex
- Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window via openalex
- LIF endometrial expression is impaired in women with unexplained infertility while LIF-R expression in all infertility sub-groups via openalex
- Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis via openalex
- Molecular Mechanisms of Treatment Resistance in Endometriosis: The Role of Progesterone–Hox Gene Interactions via openalex
- Oocyte Donation and Endometriosis: What Are the Lessons? via openalex
- Pathogenic mechanisms in endometriosis-associated infertility via openalex
- Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? via openalex
- Progesterone resistance in endometriosis: origins, consequences and interventions via openalex
- Pro-inflammatory M1/Th1 type immune network and increased expression of TSG-6 in the eutopic endometrium from women with endometriosis via openalex
- Surgery for Benign Gynecological Disorders Improve Endometrium Receptivity: A Systematic Review of the Literature via openalex
- W2461157931 via openalex
- W2162415072 via openalex
- W2129213273 via openalex
- W2761949247 via openalex
- W2792970625 via openalex
- W2088661170 via openalex
- W2927173694 via openalex
- W2003143423 via openalex
- W1978640205 via openalex
- W3007748062 via openalex
- W3016019501 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:37.768885+00:00